Shares of NYSE:SOLV opened at $77.96 on Wednesday. The business has a 50 day moving average price of $73.65 and a 200 day moving average price of $70.55. Solventum has a twelve month low of $47.16 ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1 ...

Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed.

In the final days of November, I was getting slightly concerned about a long position in Solventum Corporation (NYSE:SOLV) after shares had enjoyed a partial re-rating. By now, the healthcare spin ...

Solventum Corp. (NYSE: SOLV), which spun off from 3M Co. (NYSE: MMM) almost a year ago, has sold its purification and filtration business to Thermo Fisher Scientific in a deal worth $4.1 billion.

Solventum is selling its purification and filtration business to Thermo Fisher for $4.1 billion, using most of the proceeds to reduce debt. The deal is part of Solventum’s transformation ...

Solventum (NYSE:SOLV – Get Free Report) had its price target boosted by research analysts at Mizuho from $70.00 to $82.00 in a research report issued to clients and investors on Monday ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 per share was 7.8% above analysts ...

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 ...